Asbestos-related pleural disease

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 4, 2012, Pages 377-381

  Myers, Renelle ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

asbestos related pleural disease; benign asbestos related pleural effusion; mesothelioma; pleural plaques

Indexed keywords

ASBESTOS; CISPLATIN; FOLIC ACID ANTAGONIST;

BENIGN ASBESTOS RELATED PLEURAL EFFUSION; CANCER COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DECORTICATION; DIAGNOSTIC IMAGING; DIFFUSE PLEURA THICKENING; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG CANCER; LUNG RESECTION; LUNG VOLUME; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA BIOPSY; PLEURA DISEASE; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURA PLAQUE; PLEURA THICKENING; PLEURECTOMY; PLEURODESIS; RESPIRATORY AIRFLOW; REVIEW; THORACOSCOPY; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

ASBESTOS; HUMANS; INHALATION EXPOSURE; MESOTHELIOMA; PLEURAL DISEASES;

EID: 84862217023     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328354acfe     Document Type: Review

References (26)

1. Mason RJ, Broaddus VC, Martin TR, et al. Murray and Nadel's textbook of respiratory medicine. Philadelphia, PA: Saunders; 2010.
2. Antao VC, Larson TC, Horton DK. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases. Curr Opin Pulm Med 2012; 18:161-167.
3. American Thoracic Society. Diagnosis and initial management of nonmalignant disesases related to asbestos. Am J Resp Crit Care Med 2004; 170: 691-715.
4. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994; 105:144-150.
5. Roberts HC, Patsios DA, Paul NS, et al. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol 2009; 4:620-628.
6. Elshazley M, Shibata E, Hisanaga N, et al. Pleural plaque profiles on the chest radiographs and CT scans of asbestos-exposed Japanese construction workers. Ind Health 2011; 49:626-633.This study compares CXR with HRCT scan to identify pleural plaques. They found that the use of a morphology-based classification of pleural plaques, including the location, width, and extent, improved plaque detection on CXR.
7. Clin B, Paris C, Ameille J, et al. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax 2011; 66:985-991.A large study consisting of 2743 participants examining the effects of asbestosrelated pleural plaques on pulmonary function studies. A restrictive pattern is identified with a linear relationship between the plaque burden and amount of restriction.
8. Miller A, Bhuptani A, Sloane MF. Cardioresoiratory responses to incremental exercise in patients with asbestos-related pleural thickening and normal or slightly abnormal lung function. Chest 1993; 103:1045-1050.
9. Mukherjee S, deKlerk N, Palmer LJ, et al. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med 2000; 162:1807-1811.
10. Allen RKA, Cramond T, Lennon D, et al. A retrospective study of chest pain in benign asbestos pleural disease. Pain Med 2011; 12:1303-1308.
11. Miles SE, Sandrini A, Johnson AR, et al. Clinical consequences of asbestosrelated diffuse pleural thickening: A review. J Occup Med Toxicol 2008; 3:20.
12. Ernst P, Zejda J. Pleural and airway disease associated with mineral fibers. In Liddell D, Miller K, editors. Mineral fibers and health. Boca Raton, FL: CRC; 1991. pp. 121-134.
13. Begin R, Samet JM, Shaikh RA. Asbestos. In Harber P, Schenker MB, Balmes JR, editors. Occupational and environmental respiratory disease. St. Louis: Mosby; 1995. pp. 293-329.
14. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987; 71:113-121.
15. Scherpereel A, Astoul P, Baas P. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35:479-495.
16. Harvey JC, Fleischman EH, Kagan AR, et al. Malignant pleural mesothelioma: A survival study. J Surg Oncol 1990; 45:40-42.
17. Ceresoli GL, Locati LD, Ferreri AJM, et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 2001; 34:279-287.
18. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002; 22:298-305.
19. Tsujimura T, Ikuko Torii, Ayuko Sato, et al. Pathological and molecular biological approaches to early mesothelioma. Int J Clin Oncol 2012; 17:40-47. Review of cytological features of MPM in pleural effusions and the major issues in pathological and molecular approaches for diagnosis of early-stage MPM.
20. Robinson BW, Creaney J, Lake R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003; 362:1612-1616.
21. Wang ZJ, Reddy GP, Gotway MB, et al. Malignant pleural mesothelioma: Evaluation with CT, MR imaging, and PET. RadioGraphics 2004; 24:105-119.
22. Zellos LS, Sugarbaker DJ. Diffuse malignant mesothelioma of the pleural space and its management. Oncology (Huntingt) 2002; 16:907-913.
23. Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: An harmful approach. Lung Cancer 2012. doi: 10.1016/j.lungcan2011.12.009. [Epub ahead of print] A prospective, nonrandomized study evaluating the impact on long-term quality of life and disease control of two surgical procedures used in the treatment of malignant pleural mesothelioma (extrapleural pneumonectomy and pleurectomy/ decortication).
24. Hughes A, Calvert P, Azzabi A, et al. Phase I clinical and pharmocokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J Clin Oncol 2002; 20:3533-3544.
25. Volgelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21:2636-2644.
26. Ellis P, Davies A, Evans WK, et al. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and practice guideline. J Thorac Oncol 2006; 1:591-601.